Clinical Trials Directory

Trials / Completed

CompletedNCT00415415

Factors Associated With Coronary Heart Disease in African Americans in the Jackson Heart Study

Disparities in CHD in the Jackson Heart Study

Status
Completed
Phase
Study type
Observational
Enrollment
5,302 (planned)
Sponsor
National Heart, Lung, and Blood Institute (NHLBI) · NIH
Sex
All
Age
35 Years – 84 Years
Healthy volunteers
Not accepted

Summary

Coronary heart disease (CHD) is the leading cause of deaths that are related to cardiovascular disease in the United States, and Mississippi's CHD mortality rate is the highest in the nation. This study will examine data from the Jackson Heart Study to determine the effect of socioeconomic status and psychosocial factors on CHD risk in African Americans in Mississippi.

Detailed description

CHD is a disease that is characterized by narrowing of the coronary arteries that supply blood to the heart. As a result, insufficient amounts of oxygen and nutrients reach the heart, which can cause chest pain or heart attack. Studies have shown that people's socioeconomic status is associated with their health, and that African Americans experience the highest rates of heart disease in the U.S. The Jackson Heart Study (JHS) is currently being conducted in Jackson, Mississippi, and is studying the factors that influence the development of cardiovascular disease in African American men and women. This study will examine data from the JHS to determine the effect of socioeconomic status and psychosocial factors on CHD risk in African Americans in Mississippi. This study will recruit participants from the JHS only. Participants will report to the study site at least once for 4.5 hours for baseline measurements. Visits will include measurements of body size and blood pressure, an electrocardiogram, an echocardiogram, an ultrasound of the carotid artery, blood and urine collection, a lung function test, and interviews regarding health status and sociocultural aspects of life. Follow-up evaluations will occur 5 and 10 years after starting the study. Outcomes will include self-report and electrocardiogram-defined CHD, as well as measures of various social and psychological factors.

Conditions

Timeline

Start date
2000-09-01
Completion
2004-03-01
First posted
2006-12-22
Last updated
2016-07-29

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00415415. Inclusion in this directory is not an endorsement.